View Post

The WHO Clarifies Antigen Composition of COVID-19 Vaccines

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) today confirmed it continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 infection and COVID-19 vaccination, and the performance of COVID-19 vaccines against circulating variants.
As of May 2025, the currently circulating SARS-CoV-2 variants are derived from JN.1.

View Post

Fatal MERS Outbreak Confirmed in Arabia

In COVID-19, Latest News by Precision Vaccinations

Recent cases and fatalities of Middle East respiratory syndrome coronavirus (MERS-CoV) show that this severe virus continues to pose a threat in countries where it is found in dromedary camels.
Additionally, it remains a risk for healthcare workers.
According to the World Health Organization (WHO) Disease Outbreak News published on May 12, 2025, the Ministry of Health of the Kingdom of Saudi Arabia (KSA) reported nine cases of MERS-CoV infection and two fatalities between March and April 21, 2025.

View Post

66% of Infants Protected Against RSV

In COVID-19, Latest News by Precision Vaccinations

As the current respiratory syncytial virus (RSV) season ends, most infants are protected against this severe disease.
According to the U.S. CDC's MMWR ( 74(16);273–281) published on May 8, 2025, in the first RSV season with widespread availability of maternal vaccine and long-acting monoclonal antibody, RSV-associated hospitalization rates among infants were lower than in prepandemic seasons.

View Post

Mpox Vaccination Protects Children From Disease

In COVID-19, Latest News by Precision Vaccinations

In recent years, the world has experienced a rise in new and deadly infectious diseases, posing a significant threat to global health.
The global mpox outbreak that began in the Canary Islands in May 2022 is a stark reminder of our natural vulnerability to new viruses.
While some of these viruses are new and relatively unknown, others, such as the monkeypox virus (MPXV), have been present since the 1970s but have primarily been endemic to some areas of central Africa, mainly impacting adults.

View Post

Chikungunya Infection Can Be Severe in Children

In COVID-19, Latest News by Precision Vaccinations

Most international travelers know infected mosquitoes transmit chikungunya, dengue, and Zika viruses. However, when an infected person seeks medical care, it can be challenging to identify which arbovirus they have contracted.
The recent outbreak of chikungunya virus (CHIKV) outbreaks in India has gained attention because of its unusual symptoms, the increased need for hospitalization, and the high level of morbidity associated with the illness.

View Post

Gulf of America's Overlapping Chikungunya, Dengue, Malaria and Zika Risk

In COVID-19, Latest News by Precision Vaccinations

Over the last few decades, the continental United States has seen an unprecedented rise in local transmission of infectious diseases previously considered to be associated only with international travel.
These mosquito-transmitted diseases include malaria, dengue, chikungunya, and Zika.
Scientific models recently predicted that the risk of mosquito-transmitted diseases will continue to increase, particularly in the southern states along the Gulf of America, such as Florida and Texas.